Publications

Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?.

JIT, M; Hutubessy, R;

2016

Applied health economics and health policy, (2016).14 3 10.1007/s40258-016-0224-7.

Generation of virus-like particles for emerging epizootic haemorrhagic disease virus: Towards the development of safe vaccine candidates.

ALSHAIKHAHMED, K; ROY, P;

2016

Vaccine, (2016).34 8 10.1016/j.vaccine.2015.12.069.

Vaccine trust and the limits of information.

LARSON, HJ;

2016

Science (New York, NY), (2016).353 6305 10.1126/science.aah6190.

Influenza Vaccination Generates Cytokine-Induced Memory-like NK Cells: Impact of Human Cytomegalovirus Infection.

GOODIER, MR; Rodriguez-Galan, A; Lusa, C; Nielsen, CM; Darboe, A; Moldoveanu, AL; White, MJ; BEHRENS, R; RILEY, EM;

2016

Journal of immunology (Baltimore, Md, (2016).197 1 10.4049/jimmunol.1502049.

Impact and Cost-effectiveness of Selective Human Papillomavirus Vaccination of Men Who Have Sex With Men.

Lin, A; Ong, KJ; Hobbelen, P; King, E; Mesher, D; EDMUNDS, WJ; Sonnenberg, P; Gilson, R; Bains, I; Choi, YH; TANTON, C; Soldan, K; JIT, M;

2016

Clinical infectious diseases, (2016).64 5 10.1093/cid/ciw845.

Feasibility and acceptability of delivering adolescent health interventions alongside HPV vaccination in Tanzania.

WATSON-JONES, D; LEES, S; Mwanga, J; Neke, N; Changalucha, J; Broutet, N; Maduhu, I; KAPIGA, S; Chandra-Mouli, V; Bloem, P; ROSS, DA;

2016

Health policy and planning, (2016).31 6 10.1093/heapol/czv119.

Simulation-guided phase 3 trial design to evaluate vaccine effectiveness to prevent Ebola virus disease infection: Statistical considerations, design rationale, and challenges.

Vandebosch, A; Mogg, R; Goeyvaerts, N; Truyers, C; GREENWOOD, B; WATSON-JONES, D; Herrera-Taracena, G; Parys, W; Vangeneugden, T;

2016

Clinical trials (London, England), (2016).13 1 10.1177/1740774515621059.

The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey.

LARSON, HJ; DE FIGUEIREDO, A; Xiahong, Z; SCHULZ, WS; Verger, P; Johnston, IG; Cook, AR; Jones, NS;

2016

EBioMedicine, (2016).12, 10.1016/j.ebiom.2016.08.042.

The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries.

HOWARD, N; MOUNIER-JACK, S; GALLAGHER, KE; Kabakama, S; GRIFFITHS, UK; Feletto, M; LaMontagne, DS; BURCHETT, HE D; WATSON-JONES, D;

2016

Human vaccines & immunotherapeutics, (2016).12 9 10.1080/21645515.2016.1178433.

Real-time qPCR improves meningitis pathogen detection in invasive bacterial-vaccine preventable disease surveillance in Fiji.

Dunne, EM; Mantanitobua, S; Singh, SP; Reyburn, R; Tuivaga, E; Rafai, E; Tikoduadua, L; Porter, B; Satzke, C; Strachan, JE; Fox, KK; Jenkins, KM; Jenney, A; Baro, S; MULHOLLAND, EK; Kama, M; Russell, FM;

2016

Scientific reports, (2016).6 1 10.1038/srep39784.